These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 13229597)
1. [Isoniazid treatment of experimental tuberculosis in guinea pigs following prolonged administration of the same drug]. MORICHI G Arch Ital Sci Farmacol; 1954 Jul; 4(3):306-8. PubMed ID: 13229597 [No Abstract] [Full Text] [Related]
2. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig. Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043 [TBL] [Abstract][Full Text] [Related]
3. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Pandey R; Khuller GK Tuberculosis (Edinb); 2005 Jul; 85(4):227-34. PubMed ID: 15922668 [TBL] [Abstract][Full Text] [Related]
4. [The influence of isoniazid administration on experimental tuberculosis of guinea pigs previously vaccinated with BCG]. MAEDA M; HARASAWA M; KOYAMA K; NAKAMOTO T Kekkaku; 1958 Sep; 33(9):620-4; English abstract 647. PubMed ID: 13599185 [No Abstract] [Full Text] [Related]
5. [Simultaneous administration of large doses of tuberculin and isoniazid in the treatment of experimental tuberculosis in guinea pigs]. DURISIC M Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1955; 7(1-4):205-8. PubMed ID: 13405402 [No Abstract] [Full Text] [Related]
6. THE FOCUS OF INOCULATION IN GUINEA PIGS DURING TREATMENT WITH MORFOZINAMIDE. (INFECTION WITH STRAINS SENSITIVE AND RESISTANT TO CHEMOTHERAPY AND ANTIBIOTICS. CATENA E; ALIPERTA A; ROCCO V Arch Tisiol Mal Appar Respir; 1963 Apr; 18():366-77. PubMed ID: 14055802 [No Abstract] [Full Text] [Related]
7. The antituberculosis activity of isoniazid in combination with sulfisoxazole (gantrisin). II. The effect of isoniazid in combination with sulfisoxazole on the experimental tuberculosis in guinea pigs and mice. NAITO M; MAEKAWA N; KUBO T; HAMADA K; TSUJINO H Acta Tuberc Jpn; 1960 Dec; 10():57-66. PubMed ID: 13727548 [No Abstract] [Full Text] [Related]
8. Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers. Pandey R; Khuller GK J Antimicrob Chemother; 2004 Apr; 53(4):635-40. PubMed ID: 14998985 [TBL] [Abstract][Full Text] [Related]
9. Lung specific stealth liposomes as antitubercular drug carriers in guinea pigs. Pandey R; Sharma S; Khuller GK Indian J Exp Biol; 2004 Jun; 42(6):562-6. PubMed ID: 15260105 [TBL] [Abstract][Full Text] [Related]
10. [Effects of prednisolone and or isoniazid on experimental pulmonary cavitary tuberculosis in guinea pigs. I]. ADACHI I; TAKAHASI T; SHIMADA H; OKAI T Kekkaku; 1961 Apr; 36():227-32. PubMed ID: 13681292 [No Abstract] [Full Text] [Related]
11. [Treatment of experimental tuberculosis in guinea pigs with varying doses of isoniazid]. NASTA M; NEGULESCU V; ALGEORGE G; ARHIRI M Bul Stiint Sect Stiint Medicale Acad Republicii Pop Romane; 1957; 9(1):105-11. PubMed ID: 13500018 [No Abstract] [Full Text] [Related]
12. [Treatment of chronic experimental tuberculosis in guinea pigs with isoniazid daily and every third day]. ZEBROWSKI T; PIENIAZEK J; BOROWIECKA A Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1954; 111(4):335-9. PubMed ID: 13181800 [No Abstract] [Full Text] [Related]
13. New approaches to the treatment of latent tuberculosis. Sterling TR Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686 [TBL] [Abstract][Full Text] [Related]
14. [Animal experimental studies on an intermittent chemotherapy and prevention of tuberculosis. VII. Success of continuous and intermittent doses of isoniazid and the triple combination isoniazid, streptomycin, PAS in a therapeutic test in guinea pigs]. BARTMANN K; VILLNOW J; SCHWARZ C Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1958; 118(5):297-313. PubMed ID: 13596285 [No Abstract] [Full Text] [Related]
15. [Wide range of the use of natural lipases and esterases to inhibit Mycobacterium tuberculosis]. Annenkov GA; Klepikov NN; Martynova LP; Puzanov VA Probl Tuberk Bolezn Legk; 2004; (6):52-6. PubMed ID: 15315135 [TBL] [Abstract][Full Text] [Related]
16. Latent tuberculosis infection in children: a call for revised treatment guidelines. Finnell SM; Christenson JC; Downs SM Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008 [TBL] [Abstract][Full Text] [Related]
17. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis. Pandey R; Sharma S; Khuller GK Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096 [No Abstract] [Full Text] [Related]
18. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis. Sharma A; Sharma S; Khuller GK J Antimicrob Chemother; 2004 Oct; 54(4):761-6. PubMed ID: 15329364 [TBL] [Abstract][Full Text] [Related]
19. [Animal experimental studies on an intermittent chemotherapy and prophylaxis of tuberculosis. VI. Infection immunity of guinea pigs in a tuberculosis treated prophylactically with isoniazid]. BARTMANN K; VILLNOW J; SCHWARZ C Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1958; 118(2):87-101. PubMed ID: 13535519 [No Abstract] [Full Text] [Related]
20. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages. Chanwong S; Maneekarn N; Makonkawkeyoon L; Makonkawkeyoon S Tuberculosis (Edinb); 2007 Mar; 87(2):130-3. PubMed ID: 16860611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]